Delving into the Latest Updates on Beijing Jiashi Lianbo Medicine Technology Co., Ltd. with Synapse

Overview

Tags

Respiratory Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Immune System Diseases	1
Infectious Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

M1 receptor x M3 receptor	1

To observe the safety and tolerability of single and continuous administration of bencyclidine bromide inhalation aerosol to healthy subjects, evaluate the safe dosage range of bencyclidine bromide inhalation aerosol, determine the maximum tolerated dose in humans, and provide a basis for formulating the dosing regimen for Phase II clinical trials.

Start Date09 Sep 2015

Sponsor / Collaborator

Beijing Jiashi Lianbo Medicine Technology Co., Ltd.

[+2]

CTR20131832

/ CompletedNot Applicable

富马酸卢帕他定片在中国健康志愿者中的药代动力学研究

[Translation] Study on the pharmacokinetics of rupatadine fumarate tablets in Chinese healthy volunteers

主要目的：旨在研究北京嘉事联博医药科技有限公司申请、石家庄以岭药业股份有限公司生产的富马酸卢帕他定片在中国健康成年志愿者体内的药代动力学特征。

[Translation]

Main objective: To study the pharmacokinetic characteristics of rupatadine fumarate tablets in healthy adult volunteers in China, which were applied for by Beijing Jiashi Lianbo Pharmaceutical Technology Co., Ltd. and produced by Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Start Date23 Dec 2012

Sponsor / Collaborator

Beijing Jiashi Lianbo Medicine Technology Co., Ltd.

[+1]

100 Clinical Results associated with Beijing Jiashi Lianbo Medicine Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Beijing Jiashi Lianbo Medicine Technology Co., Ltd.

Login to view more data

100 Deals associated with Beijing Jiashi Lianbo Medicine Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Beijing Jiashi Lianbo Medicine Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 16 Sep 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

1

Other

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Bencycloquidium Bromide ( M1 receptor x M3 receptor )	Pulmonary Disease, Chronic Obstructive More	Phase 1
Iso-phenylcyclopentylamine Hydrochloric ( DAT x NET x SERT )	Obesity More	Pending